Semaglutide during stem cell transplant for lymphoma
Treatments studied
Part of Cancer, Digestive system, Immune system & allergy clinical trials.
This trial tests whether taking semaglutide, a medicine used for diabetes and weight loss, can improve recovery in patients with lymphoma who are having a stem cell transplant. It may help reduce complications and improve overall outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been referred for a stem cell transplant for relapsed diffuse large B-cell lymphoma or follicular lymphoma.
- You are at least 18 years old.
- Your body mass index (BMI) is at least 18.5.
- You are able to perform daily activities with some help (ECOG performance status 2 or better).
- You can read and understand Danish or English.
- You do not have diabetes, inflammatory bowel disease, a history of pancreatitis, or certain genetic conditions.
- You do not have severe kidney or liver problems.
- You are not allergic to semaglutide or similar medicines.
- You are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if an oral semaglutide pill can reduce liver fat and improve body composition in people who have had a liver transplant and have diabetes. It may help manage weight and blood sugar after transplant.
This trial tests semaglutide, a medicine that helps lower blood sugar, in people who develop high blood sugar shortly after a kidney transplant. It may help control blood sugar without harming the transplanted kidney, while also checking safety in this specific group.
This trial tests whether the medication semaglutide (often used for diabetes) can prevent the development of new diabetes after a kidney transplant. If you are in the early weeks after a transplant and have risk factors for diabetes, this study might help reduce your chances of developing diabetes later.
This study checks whether semaglutide is safe and feasible for people with advanced lung diseases and higher body weight. It may help by testing a structured treatment approach, but it includes several health and safety limits.
This trial tests semaglutide (a diabetes/weight-loss medicine) to help prevent weight gain after liver transplant. It is also looking at blood sugar and safety while you continue your transplant medicines.
This study tests whether semaglutide (a medication used for weight management) can help people on buprenorphine or methadone reduce their opioid use. If it works, it could provide additional support during recovery.
Hear when a new Chemotherapeutic Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.